Low risk of seroconversion or clinical disease in humans after a bite by an Anaplasma phagocytophilum-infected tick  by Henningsson, Anna J. et al.
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The  risk  of  contracting  human  granulocytic  anaplasmosis  (HGA)  after  a tick bite  is mainly  unknown.  In
this study  we  investigated  the  clinical  and  serological  response  in 30 humans  bitten  by ticks  positive  for
Anaplasma  phagocytophilum  (Group  A), 30 humans  bitten  by  Borrelia  burgdorferi  sensu  lato  (s.l.)-positive
ticks  (Group  B),  and  30 humans  bitten  by ticks  negative  for both  A. phagocytophilum  and  B. burgdorferi  s.l.
(Group  C).  Ticks,  blood  samples  and  questionnaires  were  collected  from  tick-bitten  humans  at  34  primary
healthcare  centres  in Sweden  and  in the Åland  Islands,  Finland,  at the  time  of  the  tick  bite and  after  three
months.  A  total  of  2553  ticks  detached  from  humans  in  2007–2009  were  analyzed  by  polymerase  chain
reaction,  and  31  (1.2%)  were  positive  for A.  phagocytophilum, 556  (21.8%)  were  positive  for B.  burgdorferi
s.l.,  and  eight  (0.3%)  were  co-infected  by A. phagocytophilum  and  B.  burgdorferi  s.l.  The  overall  prevalence
of  Anaplasma  IgG  antibodies  in  the  included  participants  (n =  90)  was  17%,  and  there  was  no signiﬁcant
difference  between  the groups  A-C. Only  one  of the  participants  (in  Group  C)  showed  a  four-fold  increasehrlichiosis of  IgG  antibodies  against  A. phagocytophilum  at the  three-month  follow-up,  but  reported  no  symptoms.
The  frequency  of reported  symptoms  did  not  differ  between  groups  A-C,  and  was  unrelated  to  the  ﬁndings
of  A.  phagocytophilum  and  B.  burgdorferi  s.l. in  the  detached  ticks. We  conclude  that  the  risk  for  HGA or
asymptomatic  seroconversion  after a tick  bite in  Sweden  or  in  the  Åland  Islands  is low,  even  if  the  tick  is
infected  by A. phagocytophilum.
© 2015  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CC. Introduction
Tick borne fever is a well-recognised problem in veterinary
edicine in Europe and in Scandinavia (Egenvall et al., 1997; Stuen
t al., 2002; Stuen, 2007). The causative agent, Anaplasma phagocy-
ophilum, is transmitted by Ixodes ticks, and known to occasionally
lso cause human disease (Chen et al., 1994). The ﬁrst veriﬁed
ases of human granulocytic anaplasmosis (HGA) in Europe were
eported from Slovenia in 1997, followed by cases from Sweden,
orway and the Netherlands (Petrovec et al., 1997; Lotric-Furlan
t al., 1998; Bjoersdorff et al., 1999a; van Dobbenburgh et al.,
999; Karlsson et al., 2001). HGA is typically a febrile illness
∗ Corresponding author.
E-mail address: anna.jonsson.henningsson@rjl.se (A.J. Henningsson).
ttp://dx.doi.org/10.1016/j.ttbdis.2015.07.005
877-959X/© 2015 The Authors. Published by Elsevier GmbH. This is an open access artic
.0/).BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
with headache, myalgia and malaise accompanied by leukopenia,
thrombocytopenia and elevated hepatic enzymes. The symptoms
are generally mild to moderate, and subclinical infections occur.
However, the disease course can be severe and even fatal in
immunocompromised individuals (Bakken et al., 1996b; Dahlgren
et al., 2011; Jereb et al., 2012; Schotthoefer et al., 2014). Since A.
phagocytophilum shares vectors with Borrelia burgdorferi sensu lato
(s.l.), co-infections occur (Bakken et al., 1996a; Nadelman et al.,
1997; Bjoersdorff et al., 1999b). Data from animal studies suggest
that such co-infections are more severe, possibly due to immuno-
suppression induced by A. phagocytophilum (Bakken et al., 1996b;
Thomas et al., 2001).The prevalence of A. phagocytophilum in ﬁeld-collected ticks in
Sweden was recently estimated to be 1.3–15% (Severinsson et al.,
2010). The human seroprevalence in Sweden has previously been
reported to be 8–21% (Dumler et al., 1997; Bjoersdorff et al., 1999b;
le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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Fig. 1. Map  showing the four regions where the 34 primary healthcare centres
(PHCs) are located. (A) Southernmost Sweden (12 PHCs). (B) South-central Sweden
(18 PHCs). (C) Northern Sweden (3 PHCs). (D) The Åland Islands (1 PHC). SE, Sweden;88 A.J. Henningsson et al. / Ticks and
ittesjö et al., 2001), and the seroconversion rates 3.9–11.1% per
ear in a highly endemic area in the south-east of Sweden (Wittesjö
t al., 2001). However, the importance of A. phagocytophilum as a
uman pathogen in Sweden is still uncertain, and little is known
bout co-infections with B. burgdorferi s.l. as well as the risk of
ontracting HGA after a single tick bite.
This study was part of the Scandinavian Tick-Borne Diseases
TBD) STING study described below, and the aims were to inves-
igate the prevalence of A. phagocyophilum in ticks that have bitten
umans, and to evaluate the risk for humans of developing clini-
al HGA or subclinical seroconversion against A. phagocytophilum
fter a tick bite in Sweden and on the Åland Islands, Finland, includ-
ng the risk of disease after a bite by a tick co-infected with A.
hagocytophilum and B. burgdorferi s.l.
. Material and methods
.1. Study design
This study was part of the on-going TBD STING study
Wilhelmsson et al., 2010, 2013; Fryland et al., 2011; Lindblom et al.,
014), in which tick-bitten individuals are asked to donate the tick
long with a blood sample at their local primary healthcare cen-
re (PHC). Three months later the participants are asked to come
ack to the PHC and give a second blood sample. At both visits,
he participants are also asked to ﬁll in questionnaires concerning
ocality of the tick bite, symptoms, etc. If the participants should
bserve additional tick bites during the three months study period,
hey are asked to collect those ticks as well and donate them to the
tudy (these ticks were not analyzed in the present study). Medical
ecords are scrutinized if the participants seek medical care dur-
ng the study period. Only tick-bitten individuals ≥18 years of age
nd with no immunosuppressive disease or treatment are included
n the study. No antibiotic prophylaxis is given after the tick bite
ut the study participants are ordered to seek medical care in case
hey get symptoms. The ticks and blood samples from individuals
ncluded in this particular part of the TBD STING study were col-
ected during 2007–2009 at 34 PHCs in Sweden and on the Åland
slands, Finland (Fig. 1).
.2. Ticks
The ticks that participants provided were transported and
andled as previously described (Wilhelmsson et al., 2013). All
icks were examined under a USB microscope (Dino-Lite Long
M4013TL, AnMo Electronics Corporation, Hsinchu, Taiwan) and
hotographed. Species and life stage of the ticks were determined,
s well as the coxal and scutal indices in order to estimate the
eeding duration according to Gray et al. (2005).
.3. Tick homogenization, total nucleic acid extraction and
everse transcription of nucleic acid
Tick preparation, homogenization, process of total nucleic acid
NA) extraction and reverse transcribed NA (RTNA) synthesis have
een described elsewhere; for ticks collected in 2007 (Wilhelmsson
t al., 2010) and for ticks collected in 2008–2009 (Wilhelmsson
t al., 2013). Brieﬂy, total NA was extracted using a BioRobot
48  workstation (Qiagen, Hilden, Germany) and MagAttract® RNA
issue Mini M48  Kit (Qiagen). The extractions were performed fol-
owing the protocol from the manufacturer, except for not adding
Nase to the RDD buffer, thus obtaining total NA including DNA.
or the RTNA synthesis, 20 L of the extracted total NA was  used
ogether with the IllustraTM Ready-to-Go RT-PCR Beads kit (GE
ealhcare, Amersham Place, UK) according to the manufacturer’s
nstructions.NO, Norway; FI, Finland; DK, Denmark; EE, Estonia; LV, Latvia; LT, Lithuania.
Reprinted from Lindblom et al. (2014) with permission from Elsevier.
2.4. Real-time PCR and conventional PCR assays
Detection of A. phagocytophilum DNA was based on a real-
time PCR method targeting the 16S rRNA gene. Each reaction
consisted of 12.5 L Maxima Probe qPCR Mastermix 2X (Fer-
mentas St. Leon-Rot, Germany), 0.6 L (10 M)  of each primer
(AphGERfn 5′-TAGATCCTTCTTAACGGAAGGGCG-3′ and AphGERr
5′-AAGTGCCCGGCTTAACCCGCTGGC-3′) (Sigma–Aldrich Sweden
AB, Stockholm, Sweden) (Goodman et al., 1996; Severinsson
et al., 2010), 0.25 L (10 M)  of the probe (AphGERp 5′-
[6FAM]-CTGTCGTCAGCTCGTGTCGTGAGATGTTG-[BHQ-1]-3′)
(Sigma–Aldrich Sweden AB), 6.05 L RNase free water and 5.0 L
cDNA. The reaction was  performed according to the following
thermal cycle conditions: 95 ◦C for 10 min, 45 cycles of 95 ◦C for
15 s, 60 ◦C for 30 s and 72 ◦C for 30 s.
The real-time PCR-positive samples were further analyzed
with a nested conventional PCR assay to amplify a longer
sequence of the 16S rRNA gene for species identiﬁcation. The
ﬁrst reaction consisted of 5 L Phusion HF buffer and 0.75 L
Phusion HF polymerase (2 U/L) (Thermo Fisher Scientiﬁc Inc.),
2 L (10 M)  of each primer (HGE1 5′-TCCTGGCTCAGAACGAAC-
3′ and Aph16S5nR 5′-TAGTCTTGCGACCGTAGTC-3′) (Sigma–Aldrich
Sweden AB, Stockholm, Sweden), 35.25 l RNase free water and
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Table  1
Number of collected ticks, their life stage and estimated feeding time.
Total Larvae Nymphs Adults N.D. Median feeding-time (h)
All collected ticks 2553 89 1806 612 46 31b (n = 1895)
Ticks  positive for A.p. 31 0 23 8 0 29 (n = 20)
Ticks  positive for B.b. s.l. 30a 0 21 9 0 26 (n = 27)
Ticks  negative for A.p. and B.b.s.l. 30a 0 24 5 1 37 (n = 28)
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e.D., life stage not determined; A.p., Anaplasma phagocytophilum; B.b.s.l., Borrelia bu
a Randomly selected from the collected ticks.
b Median duration of tick feeding is based on nymphs (n = 1451) and adult female
 l cDNA. The reaction was performed according to the following
hermal cycle conditions: 98 ◦C for 10 min, 35 cycles of 94 ◦C for
0 s, 60 ◦C for 45 s, and 72 ◦C for 30 s. This was followed by 72 ◦C
or 7 min. An aliquot (5 L) of the PCR product obtained in this
ssay was added to the second PCR mixture, which was prepared
sing the same volumes, concentrations, and ampliﬁcation pro-
ramme  as those used for the ﬁrst mixture, except with a different
rimer pair (Aph16SnF 5′-CAAGCTTAACACATGCAAGTCG-3′ and
ph16S6nR 5′-GAGTGCTTAACGCGTTAGCTAC-3′) (Sigma–Aldrich
weden AB, Stockholm, Sweden), and the number of cycles was
ncreased to 42. The obtained PCR products were sent to Macro-
en Inc. (Seoul, South Korea), for nucleotide sequencing based on
igDye chemistry. Sequence chromatograms were initially edited
sing BioEdit Software (V7.0) (Tom Hall, Ibis Therapeutics, Carls-
ad, CA) followed by a standard BLAST search against the GenBank
atabase (http://blast.ncbi.nlm.nih.gov).
The extraction control consisted of a real-time PCR assay tar-
eting the Ixodes 16S mitochondrial DNA, previously described by
chwaiger and Cassinotti (2003). Detection of B. burgdorferi s.l.
as performed by real-time PCR targeting the 16S rRNA gene as
escribed previously (Wilhelmsson et al., 2013).
.5. Serum samples
The acute and convalescent serum samples (collected at inclu-
ion in the study and after three months) corresponding to the
icks positive for A. phagocytophilum (Group A) were analyzed for
he presence of A. phagocytophilum IgG antibodies using a com-
ercially available indirect immunoﬂuorescent assay (IFA); (Focus
iagnostics, Cypress, CA, USA). Acute and convalescent sera from
ndividuals bitten by B. burgdorferi s.l. positive ticks (Group B), and
era from individuals bitten by ticks negative for both A. phagocy-
ophilum and B. burgdorferi s.l. (Group C) were randomly selected
or analysis regarding IgG antibodies against A. phagocytophilum.
ll serum samples had been stored at −20 ◦C before analysis and
rocessed according to the manufacturer’s instructions, except that
ilutions 1:80, 1:160, 1:320, etc. were used. End point titre was
ecorded as the reciprocal of the last serial dilution at which spe-
iﬁc apple-green ﬂuorescence of Anaplasma inclusion bodies were
ocally located in the cytoplasm of the infected cells. IFA titres
1:80 were interpreted as positive. This cut-off value was based
n local Swedish serum samples used when validating the method
Bjoersdorff et al., 1999b). For the diagnosis of on-going or recent
. phagocytophilum infection, at least a four-fold rise of the IFA
itre was required when acute and convalescent serum samples
ere tested simultaneously. All serum samples had been analyzed
reviously for the presence of antibodies against B. burgdorferi s.l.
Fryland et al., 2011).
.6. QuestionnairesThe questionnaires were scrutinized for symptoms suggestive
f HGA; fever, headache, myalgia, arthralgia and malaise (Fryland
t al., 2011).feri sensu lato.
 (n = 444).
2.7. Statistics
Comparison of clinical and serological data between groups
were performed using the chi2-test, and the Kruskal–Wallis test
was applied for comparison of feeding-time (SPSS for Windows,
version 15.0). p-Values <0.05 were considered as signiﬁcant.
2.8. Ethics
The study was approved by the Regional Ethics Review Board in
Linköping (M132-06), and by the local Ethics Committee of Åland
Healthcare, 2008-05-23. Written consent was  obtained from all
participants.
3. Results
3.1. Ticks
In total, 2553 ticks that had bitten humans were collected during
the years 2007–2009. All the collected ticks belonged to the Ixodes
ricinus species; 89 (3.5%) larvae, 1806 (70.7%) nymphs, 612 (24.0%)
adults. Forty-six (1.8%) of the ticks were so damaged that life stage
could not be determined (Table 1).
3.2. Prevalence of A. phagocytophilum and B. burgdorferi s.l. in
the ticks
Thirty-one ticks (1.2%) were positive for A. phagocytophilum, and
eight of them were co-infected with B. burgdorferi s.l. (0.3%). Five
hundred-and-ﬁfty-six ticks (21.8%) were positive for B. burgdorferi
s.l. alone (Wilhelmsson et al., 2013). Of the A. phagocytophilum-
positive ticks, 23 were nymphs and eight were adults. Feeding-time
could be estimated in 20 of the A. phagocytophilum-positive ticks;
median 29 h, range <15 h to >69 h. There were no signiﬁcant differ-
ences regarding estimated tick feeding-time between the groups
A-C (pp  = 0.47) (Table 1).
3.3. Seroprevalence, seroconversion and reported symptoms of
the tick-bitten subjects
Acute and convalescent serum samples from the thirty individ-
uals bitten by ticks positive for A. phagocytophilum were obtained
(one participant that had been bitten by an A. phagocytophilum-
and B. burgdorferi s.l.-positive adult tick was lost to follow-up).
The paired sera from the individuals bitten by A. phagocytophilum-
positive ticks were analyzed for the presence of A. phagocytophilum
IgG antibodies (Group A), as well as sera from thirty randomly
chosen individuals bitten by ticks positive for B. burgdorferi s.l.
(Group B), and thirty individuals bitten by ticks negative for both
A. phagocytophilum and B. burgdorferi s.l. (Group C). The overall
seroprevalence for A. phagocytophilum in all three groups was  17%
(15/90) with no signiﬁcant difference between the groups (Group
A: 13%, Group B: 23%, Group C: 13%, p = 0.45). None of the partici-
pants reported having had conﬁrmed HGA previously. The detected
antibody titres were 1:80 (n = 8) and 1:160 (n = 7). Six individuals
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n Group A reported symptoms (e.g. headache, neck pain, fatigue,
ertigo, myalgia, arthralgia), but none of them displayed signiﬁcant
ncrease in Anaplasma antibody titre or seroconversion. Two of the
even individuals bitten by ticks co-infected by A. phagocytophilum
nd B. burgdorferi s.l. reported symptoms but showed no antibody
esponse against any of the bacteria. Six individuals in Group B and
ve individuals in Group C reported symptoms (e.g. headache, neck
ain, fatigue, vertigo, myalgia, arthralgia, paresthesia) but showed
o seroconversion or increased antibody titres against A. phagocy-
ophilum or B. burgdorferi s.l., except for one patient in Group C that
as diagnosed with Lyme neuroborreliosis. Only one individual
n the study (in Group C) showed seroconversion for A. phagocy-
ophilum at the three-month follow-up, but reported no symptoms.
our participants showed seroconversion for B. burgdorferi s.l. dur-
ng the study period (one in Group A, two in Group B and one in
roup C), but reported no symptoms.
. Discussion
Although increasingly detected, HGA is still a rather unknown
llness in Europe (Blanco and Oteo, 2002; Strle, 2004), as opposed
o the situation in the USA where HGA is a notiﬁable disease with
ncreasing incidence (Centers for Disease Control and Prevention,
011). Underreporting, differences in host range or reduced vir-
lence in humans of the circulating A. phagocytophilum strains
n Europe may  be possible explanations, but precise knowledge
s still lacking. There is a large amount of genetically diverse A.
hagocytophilum lineages in Europe (Tveten, 2014), e.g. the mouse-
ssociated lineages comprising variants that also have been isolated
rom human cases, and the deer-associated lineages that do not
ppear to be infectious for humans (Massung et al., 2002). This
mplies that there is possibly a European risk scenario similar to
he one in the USA.
In this study, we found an A. phagocytophilum prevalence of 1.2%
n ticks that have bitten humans in Sweden or on the Åland Islands,
hich is within the same range as the prevalence found in ﬁeld-
ollected ticks from Sweden (Severinsson et al., 2010). Only 0.3% of
he analyzed ticks were co-infected with A. phagocytophilum and
. burgdorferi s.l., similar to the co-infection rates found in previ-
us studies on ﬁeld-collected ticks and ticks collected from birds in
urope (Schicht et al., 2011; Coipan et al., 2013; Soleng and Kjelland,
013; Capligina et al., 2014). To our knowledge, no previous data
n prevalence of A. phagocytophilum and co-infections with other
athogens in ticks detached from humans has been reported from
orthern Europe.
The seroprevalence of 17% that we found among the TBD STING
tudy participants is in accordance with previous studies on other
ick-exposed populations in Sweden, i.e. patients with Lyme bor-
eliosis or people living in tick-endemic areas (Dumler et al., 1997;
joersdorff et al., 1999b; Wittesjö et al., 2001). The seropreva-
ence among healthy blood donors (probably a population less
xposed to tick bites than the participants in the TBD STING study)
rom Jönköping county, using the same IFA and the same cut-off
evel as in the present study, has been found to be 8.3% (unpub-
ished data). None of the subjects in this study had been diagnosed
ith HGA previously, which may  indicate that the disease is gen-
rally mild or even asymptomatic, but it may  also indicate that
hysicians rarely suspect HGA in their patients. In this study, sub-
ects receiving immunosuppressive treatments were not included,
nd it is plausible that the course of HGA is more severe in the
mmunocompromised, as has been shown previously (Bakken et al.,
996b; Dahlgren et al., 2011; Jereb et al., 2012; Schotthoefer et al.,
014). This has also been shown for infections caused by Candidatus
eoehrlichia mikurensis, another member of the family Anaplas-
ataceae (Welinder-Olsson et al., 2010; Grankvist et al., 2014).orne Diseases 6 (2015) 787–792
We  conclude from our data that the risk of contracting HGA
after a tick bite is low even if the tick is infected by A. phagocy-
tophilum and has been feeding for ≥29 h. This corroborates previous
ﬁndings from central Europe (Tijsse-Klasen et al., 2011). There is
possibly a delay in the transmission of A. phagocytophilum from
the tick to the host, but since feeding-time could be estimated in
only 20 of the infected ticks and none of the study participants
seroconverted, no ﬁrm conclusions could be drawn from our data
regarding this. Delayed transmission has been shown for B. burgdor-
feri s.l. (Piesman et al., 1987), and attachment and partial feeding
of a B. burgdorferi s.l.-infected tick does not necessarily lead to
infection or disease (Fryland et al., 2011) which also seems to be
the case for A. phagocytophilum according to experimental stud-
ies on mice by Katavolos et al. (1998). The overall seroprevalence
of 17% in this tick-bitten population that, however, did not report
previously diagnosed HGA, may  also indicate a low risk for clini-
cal disease after exposure to A. phagocytophilum. There have been
previous reports of veriﬁed symptomatic HGA cases from Sweden,
however the incidence is low (Bjoersdorff et al., 1999a, 2002). In
European countries the number of clinically diagnosed cases of HGA
is low, while the seroprevalence of antibodies against A. phagocy-
tophilum is 2–28% (Strle, 2004). Such high levels of seropositivity
in regions with low numbers of clinical cases may be explained by
the circulation of strains that are non-pathogenic to humans or by
serologic cross-reactivity with other bacteria (Rar and Golovljova,
2001). Evidence from cross-infection experiments have indicated
that A. phagocytophilum isolates of distinct host origin are not uni-
formly infectious for other heterologous hosts (Rar and Golovljova,
2001; Jin et al., 2012). The proportion of A. phagocytophilum strains
pathogenic to humans that occur in I. ricinus ticks in Europe is still
uncertain, and results from different molecular strain characteriza-
tion studies are not easily comparable, since different gene regions
and fragment lengths have been investigated. A recent analysis of
the population structure of A. phagocytophilum based on multilo-
cus sequence typing revealed that all strains isolated from humans
in Europe belonged to the same dominating clonal complex (Huhn
et al., 2014).
The reported symptoms in any of the study groups are proba-
bly not related to HGA or Lyme borreliosis, since no corresponding
antibody responses could be detected in the reporting subjects.
Only one participant showed seroconversion against A. phago-
cytophilum at follow-up, but reported no subjective symptoms.
This participant had donated an A. phagocytophilum-,  as well as
B. burgdorferi s.l.,-negative tick, but had probably, in conjunction
with the study period, had additional tick bites that passed unno-
ticed. No increased risk for HGA or Lyme borreliosis after a bite
by a co-infected tick could be detected in this study, however the
number of individuals bitten by a co-infected tick was low (n = 7).
The number of individuals that reported symptoms during the
study period did not differ between the groups A-C, and seemed
to be unrelated to whether the biting tick contained A. phagocy-
tophilum, B. burgdorferi s.l., both or none of these two  bacteria.
Therefore, analysis of the tick after a tick bite seems to be of little
or no value for predicting disease or making treatment decisions in
humans.
We used a cut-off in the IFA of 1:80, as 1:64 and 1:80 have
been widely used for epidemiological purposes before. However,
it has previously been discussed by others whether these cut-offs
may  be set too low (Aguero-Rosenfeld et al., 2002; Walder et al.,
2003), since a signiﬁcant proportion of the population without clin-
ical evidence of HGA will then test positive for A. phagocytophilum
antibodies. Furthermore, serological cross-reactions may  compli-
cate the interpretation of IFA results. False positive results may be
due to e.g. Epstein–Barr virus infection, Lyme borreliosis or autoim-
mune disorders (Dumler et al., 2007), and this, together with the
uncertainty of the proper cut-off, should be kept in mind when
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nterpreting the results and may  be an explanation to the discrep-
ncy between the rather high seroprevalence found in our study
opulation and the low prevalence of A. phagocytophilum found in
he analyzed ticks. However, Dumler et al. (1997) found a sero-
revalence of 11.4% among inhabitants on the Koster island off the
estern cost of Sweden (cut-off 1:80), Wittesjö et al. (2001) found a
eroprevalence of 28% in inhabitants on the Aspö island located off
he southeast coast of Sweden (cut-off 1:80), and Skarphedinsson
t al. (2001) found a seroprevalence of 21% among Danish patients
ith conﬁrmed or suspected Lyme borreliosis (cut-off 1:64), so the
eroprevalence of 17% found in our study seems reasonable. As dis-
ussed above, it may  represent an over-estimate, but the selected
ut-off allows for the comparison.
Another possible limitation to the study is that the second
erum samples were collected after three months, and it cannot
e completely ruled out that a few of the subjects bitten by an
. phagocytophilum-infected tick actually did seroconvert but the
ntibody titre had dropped again at follow-up. However, this seems
ather unlikely since antibodies usually remain for several months
r longer (Bakken et al., 2002; Aguero-Rosenfeld, 2003).
In conclusion, the prevalence of A. phagocytophilum in ticks that
ave bitten humans do not differ from the prevalence found in
eld-collected ticks in Sweden and on the Åland Islands. The sero-
revalence of 17% among the study participants indicate that the
opulation in the study area is exposed to A. phagocytophilum, but
he infection is seemingly often unnoticed or at least undiagnosed
ince none of the seropositive individuals reported a previous HGA
nfection. The risk of contracting HGA after a single tick-bite is how-
ver low, even if the tick is infected with A. phagocytophilum and
as been feeding for several days. Thus, analysis of the tick after a
ick bite is not clinically useful and should be avoided since it may
ead to unnecessary anxiety for the tick-bitten individual as well as
nfounded use of antibiotics. Any ﬁrm conclusions whether the risk
f disease is increased or not after a bite by a tick co-infected with A.
hagocytophilum and B. burgdorferi s.l. could not be drawn from this
tudy due to the low number of co-infected ticks. Lyme borreliosis
nd HGA co-infections need to be further evaluated, since previous
ata is ambiguous (Belongia et al., 1999; Krause et al., 2002; Steere
t al., 2003; Horowitz et al., 2013), and animal studies suggest an
ggravated course of such infections (Bakken et al., 1996b; Thomas
t al., 2001). The continuing TBD STING study provides possibilities
o bring new insights into the interplay between ticks, tick-borne
athogens and humans, and permits improved risk assessments
or human disease following a tick bite which is important from a
ublic health perspective.
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